Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

JID Innovations, 2023
Modulation of Inflammatory Proteins in Serum May Reflect Cutaneous Immune Responses in Cancer Immunotherapy

Han J., Correa da Rosa J., Agarwal A. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationSerumTissue Lysate

PLOS ONE, 2023
Proteomics biomarker discovery for individualized prevention of familial pancreatic cancer using statistical learning

Ha C., Müller-Nurasyid M., Petrera A. et al.

Olink Target 96OncologyData ScienceSerum

ERJ Open Research, 2023
Cardiovascular disease-linked plasma proteins are mainly associated with lung volume

Rydell A., Nerpin E., Zhou X. et al.

Olink Target 96Respiratory DiseasesCVDPathophysiologyPlasma

Translational Neurodegeneration, 2023
Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Yulug B., Altay O., Li X. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Journal of the American Heart Association, 2023
High Plasma Levels of Soluble Lectin‐like Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity

Stinson S., Jonsson A., Andersen M. et al.

Olink Target 96Metabolic DiseasesCVDPatient StratificationPlasma

Clinical Proteomics, 2023
Are the results from a multiplex proteomic assay and a conventional immunoassay for NT-proBNP and GDF-15 comparable?

Skau E., Wagner P., Leppert J. et al.

Olink Target 96CVDTechnical EvaluationPlasma

BMC Medicine, 2023
Starch intake, amylase gene copy number variation, plasma proteins, and risk of cardiovascular disease and mortality

Li H., Borné Y., Wang Y. et al.

Olink Target 96CVDNutritional SciencePatient StratificationPlasma

European Journal of Preventive Cardiology, 2023
Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction

Valdes-Marquez E., Clarke R., Hill M. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Med, 2023
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors

Nuñez N., Berner F., Friebel E. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Brain Communications, 2023
Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis

Burman J., Zjukovskaja C., Svenningsson A. et al.

Olink Target 96NeurologyPatient StratificationCSF

Neurotrauma Reports, 2023
A Dedicated 21-Plex Proximity Extension Assay Panel for High-Sensitivity Protein Biomarker Detection Using Microdialysis in Severe Traumatic Brain Injury: The Next Step in Precision Medicine?

Dyhrfort P., Wettervik T., Clausen F. et al.

Olink FocusNeurologyPathophysiologyCerebral Microdialysis Fluid

Cells, 2023
Midgut Volvulus Adds a Murine, Neutrophil-Driven Model of Septic Condition to the Experimental Toolbox

Elrod J., Kiwit A., Lenz M. et al.

Olink Target 96 MouseInfectious DiseasesTechnical EvaluationPlasma

Artificial Intelligence in Medicine, 2023
Benchmarking of Machine Learning classifiers on plasma proteomic for COVID-19 severity prediction through interpretable artificial intelligence

Dimitsaki S., Gavriilidis G., Dimitriadis V. et al.

Olink Explore 3072/384Infectious DiseasesData SciencePlasma

Translational Lung Cancer Research, 2023
Circulating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small-cell lung cancer patients

Maansson C., Helstrup S., Ebert E. et al.

Olink Target 96OncologyPatient StratificationPlasma

Nature, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapy

Sun Y., Revach O., Anderson S. et al.

Olink Explore 3072/384OncologyImmunotherapyPathophysiologyPlasma

Atherosclerosis, 2023
Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort

Katra P., Hennings V., Nilsson J. et al.

Olink Target 96CVDPatient StratificationPlasma

JACC: Basic to Translational Science, 2023
Extracellular Vesicle-Associated TWEAK Contributes to Vascular Inflammation and Remodeling During Acute Cellular Rejection

Celik S., Sadrian J., Grossi M. et al.

Olink Target 96Immunological & Inflammatory DiseasesCVDPathophysiologyEV Lysate

Cell Reports, 2023
The human placenta shapes the phenotype of decidual macrophages

Vondra S., Höbler A., Lackner A. et al.

Olink Target 96ObstetricsPathophysiologyCell Culture Supernatant

Frontiers in Cardiovascular Medicine, 2023
Plasma protein profiling analysis in patients with atrial fibrillation before and after three different ablation techniques

Lin M., Bao Y., Du Z. et al.

Olink Target 96CVDTechnical EvaluationPlasma

Nature Medicine, 2023
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

Hong D., Van Tine B., Biswas S. et al.

Olink Target 96OncologyPathophysiologySerum

3556 publications